Roquinimex is a derivative of quinoline that presents immunostimulant properties. Its effects are suggested to increase the activity of NK cells and macrophage cytotoxicity. Additionally, roquinimex is known to inhibit angiogenesis and to decrease the synthesis of TNF alpha. The directory classifies it as a discontinued API with a synthetic source/manufacturing origin. Other names for this substance include Linomide and Roquinimexum. Its PubChem CID is 54676478.
Roquinimex
| CAS No | 84088-42-6 |
|---|---|
| Molecular Formula | C18H16N2O3 |
| Molecular Weight | 308.3 g/mol |
| Synonyms | 4-hydroxy-N,1-dimethyl-2-oxo-N-phenylquinoline-3-carboxamide |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Roquinimex is a derivative of quinoline that presents immunostimulant properties. Its effects are suggested to increase the activity of NK cells and macrophage cytotoxicity.
The listed CAS number is 84088-42-6.
The listed molecular formula is C18H16N2O3.
The listed molecular weight is 308.3 g/mol.
4-hydroxy-N,1-dimethyl-2-oxo-N-phenylquinoline-3-carboxamide.
The source lists Linomide and Roquinimexum.